Incyte Genomics (INCY) Misses Q2 Views
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $114.23 -2.12%
Revenue Growth %: +34.1%
Financial Fact:
Contract revenues: 3.21M
Today's EPS Names:
CCEL, MHGU, PLG, More
Revenue Growth %: +34.1%
Financial Fact:
Contract revenues: 3.21M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Incyte Genomics (NASDAQ: INCY) reported Q2 EPS of ($0.41), $0.05 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $19.17 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) PT Raised to $112 at BMO Capital
- Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance
- Levi (LEVI) Tops Q2 EPS by 4c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
